- Home
- CHRD vs TMDX Comparison
CHRD vs TMDX Comparison
Compare CHRD & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CHRD | TMDX |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.6B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CHRD | TMDX |
|---|---|---|
| Price | $104.66 | $132.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $124.18 | ★ $144.25 |
| AVG Volume (30 Days) | 598.3K | ★ 651.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.09% | N/A |
| EPS Growth | N/A | ★ 231.17 |
| EPS | N/A | ★ 2.28 |
| Revenue | N/A | ★ $441,540,000.00 |
| Revenue This Year | N/A | $38.73 |
| Revenue Next Year | N/A | $20.55 |
| P/E Ratio | ★ $34.53 | $59.34 |
| Revenue Growth | N/A | ★ 82.74 |
| 52 Week Low | $79.83 | $62.07 |
| 52 Week High | $116.09 | $156.00 |
Technical Indicators
Market Signals| Indicator | CHRD | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 60.12 | 48.68 |
| Support Level | $97.40 | $127.50 |
| Resistance Level | $103.14 | $137.49 |
| Average True Range (ATR) | 3.39 | 6.14 |
| MACD | 0.17 | -0.33 |
| Stochastic Oscillator | 90.64 | 43.67 |
Price Performance
Historical ComparisonAbout CHRD Chord Energy Corporation
Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.